Susceptibilities of simian immunodeficiency virus to protease inhibitors
We used a focal infectivity assay with HeLa H1-JC.37 cells to directly compare susceptibilities of simian immunodeficiency virus (SIV) and human immunodeficiency virus type 1 (HIV-1) to protease inhibitors. SIVmac239 was inhibited by indinavir, saquinavir, and ritonavir, with 50% effective concentrations (means +/- standard deviations) of 39 +/- 8, 55 +/- 3, and 13 +/- 5 nM, respectively. The corresponding values for inhibition of HIV-1 were 66 +/- 4, 47 +/- 10, and 25 +/- 14 nM, respectively.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2003 |
---|---|
Erschienen: |
2003 |
Enthalten in: |
Zur Gesamtaufnahme - volume:47 |
---|---|
Enthalten in: |
Antimicrobial agents and chemotherapy - 47(2003), 5 vom: 22. Mai, Seite 1756-9 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Giuffre, Angelica C [VerfasserIn] |
---|
Themen: |
5W6YA9PKKH |
---|
Anmerkungen: |
Date Completed 12.08.2003 Date Revised 26.05.2021 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM124803253 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM124803253 | ||
003 | DE-627 | ||
005 | 20231222204337.0 | ||
007 | tu | ||
008 | 231222s2003 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0416.xml |
035 | |a (DE-627)NLM124803253 | ||
035 | |a (NLM)12709355 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Giuffre, Angelica C |e verfasserin |4 aut | |
245 | 1 | 0 | |a Susceptibilities of simian immunodeficiency virus to protease inhibitors |
264 | 1 | |c 2003 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 12.08.2003 | ||
500 | |a Date Revised 26.05.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a We used a focal infectivity assay with HeLa H1-JC.37 cells to directly compare susceptibilities of simian immunodeficiency virus (SIV) and human immunodeficiency virus type 1 (HIV-1) to protease inhibitors. SIVmac239 was inhibited by indinavir, saquinavir, and ritonavir, with 50% effective concentrations (means +/- standard deviations) of 39 +/- 8, 55 +/- 3, and 13 +/- 5 nM, respectively. The corresponding values for inhibition of HIV-1 were 66 +/- 4, 47 +/- 10, and 25 +/- 14 nM, respectively | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, U.S. Gov't, P.H.S. | |
650 | 7 | |a HIV Protease Inhibitors |2 NLM | |
650 | 7 | |a Indinavir |2 NLM | |
650 | 7 | |a 5W6YA9PKKH |2 NLM | |
650 | 7 | |a Saquinavir |2 NLM | |
650 | 7 | |a L3JE09KZ2F |2 NLM | |
650 | 7 | |a Ritonavir |2 NLM | |
650 | 7 | |a O3J8G9O825 |2 NLM | |
700 | 1 | |a Higgins, Joanne |e verfasserin |4 aut | |
700 | 1 | |a Buckheit, Robert W |c Jr |e verfasserin |4 aut | |
700 | 1 | |a North, Thomas W |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Antimicrobial agents and chemotherapy |d 1972 |g 47(2003), 5 vom: 22. Mai, Seite 1756-9 |w (DE-627)NLM000026506 |x 1098-6596 |7 nnns |
773 | 1 | 8 | |g volume:47 |g year:2003 |g number:5 |g day:22 |g month:05 |g pages:1756-9 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 47 |j 2003 |e 5 |b 22 |c 05 |h 1756-9 |